Исторические и современные аспекты диагностики и лечения обструктивной гипертрофической кардиомиопатии: обзор литературы

Автор: Каштанов М.Г., Идов Э.М.

Журнал: Патология кровообращения и кардиохирургия @journal-meshalkin

Рубрика: Обзоры

Статья в выпуске: 1 т.20, 2016 года.

Бесплатный доступ

Гипертрофическая кардиомиопатия - редкая, но сложная патология. В последние 70 лет осуществлен значительный рывок в понимании патогенеза данной болезни, а также диагностике и лечении. В обзоре литературы суммированы данные первоисточников и представлено современное видение проблемы. В статье также рассмотрены вопросы хирургического и интервенционного лечения пациентов с гипертрофической кардиомиопатией. Особое внимание уделено этаноловой аблации септальной гипертрофии.

Гипертрофическая кардиомиопатия, хирургическая миэктомия, этаноловая аблация септальной гипертрофии

Короткий адрес: https://sciup.org/142140728

IDR: 142140728

Список литературы Исторические и современные аспекты диагностики и лечения обструктивной гипертрофической кардиомиопатии: обзор литературы

  • Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., Bild D.E. Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults: Echocardiographic Analysis of 4111 Subjects in the CARDIA Study//Circulation. 1995. Vol. 92 (4). P. 785-789 DOI: 10.1161/01.CIR.92.4.785
  • Hada Y., Sakamoto T., Amano K., Yamaguchi T., Takenaka K., Takahashi H., Takikawa R., Hasegawa I., Takahashi T., Suzuki J. et al. Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening//Am. J. Cardiol. 1987. Vol. 59 (1). P. 183-184.
  • Codd M.B., Sugrue D.D., Gersh B.J., Melton L.J. 3rd. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984//Circulation. 1989. Vol. 80 (3). P. 564-572.
  • Corrado D., Basso C., Schiavon M., Thiene G. Screening for hypertrophic cardiomyopathy in young athletes//N. Engl. J. Med. 1998. Vol. 339 (6). P. 364-369. doi: 10.1056/NEJM199808063390602
  • Maron B.J., Mathenge R., Casey S.A., Poliac L.C., Longe T.F. Clinical profile of hyper-trophic cardiomyopathy identified de novo in rural communities//J. Am. Coll. Cardiol. 1999. Vol. 33 (6). P. 1590-1595.
  • Nistri S., Thiene G., Basso C., Corrado D., Vitolo A., Maron B.J. Screening for hypertrophic cardiomyopathy in a young male military population//Am. J. Cardiol. 2003. Vol. 91 (8). P. 1021-1023, A8.
  • Zou Y., Song L., Wang Z., Ma A., Liu T., Gu H., Lu S., Wu P., Zhang Y., Shen L., Cai Y., Zhen Y., Liu Y., Hui R. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults//Am. J. Med. 2004. Vol. 116 (1). P. 14-18.
  • Maron B.J., Spirito P., Roman M.J., Paranicas M., Okin P.M., Best L.G., Lee E.T., Devereux R.B. Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study)//Am. J. Cardiol. 2004. Vol. 93 (12). P. 1510-1514.
  • Maro E.E., Janabi M., Kaushik R. Clinical and echocardiographic study of hypertrophic cardiomyopathy in Tanzania//Trop. Doct. 2006. Vol. 36 (4). P. 225-227.
  • Ng C.T., Chee T.S., Ling L.F., Lee Y.P., Ching C.K., Chua T.S., Cheok C., Ong H.Y. Prevalence of hypertrophic cardiomyopathy on an electrocardiogram-based pre-participation screening programme in a young male South-East Asian population: results from the Singapore Armed Forces Electrocardiogram and Echocardiogram screening protocol//Europace. 2011. Vol. 13 (6). P. 883-888 DOI: 10.1093/europace/eur051
  • Maron M.S., Olivotto I., Betocchi S., Casey S.A., Lesser J.R., Losi M.A., Cecchi F., Maron B.J. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy//N. Engl. J. Med. 2003. Vol. 348 (4). P. 295-303 DOI: 10.1056/NEJMoa021332
  • Liouville H. Rétrécissement cardiaque sous aortique//Gazette Med. Paris. 1869. Vol. 24. P. 161-163.
  • Vulpian A. Contribution à l’étude des rétrécissements de l’orifice ventriculo-aortique//Arch Pathol. 1868. Vol. 3. P. 456-457.
  • Hallopeau M. Rétrécissement ventriculo-aortique//Gazette Med. Paris. 1869. Vol. 24. P. 683.
  • Schmincke A. Ueber linkseitige muskulose conustenosen//Dtsch Med Wochenschr. 1907. Vol. 33. P. 2082-2085.
  • Levy R.L., von Glahn W.C. Cardiac hypertrophy of unknown cause. A study of the clinical and pathologic features in ten adults//Am. Heart J. 1944. Vol. 28 (6). P. 714-741.
  • Evans W. Familial cardiomegaly//Br. Heart J. 1949. Vol. 11 (1). P. 68-82.
  • Brock R.C. Functional obstruction of the left ventricle (acquired aortic subvalvar stenosis)//Guys Hosp. Rep. 1957. Vol. 106 (4). P. 221-238.
  • Teare D. Asymmetrical hypertrophy of the heart in young adults//Br. Heart J. 1958. Vol. 20 (1). P. 1-8.
  • Morrow A.G., Braunwald E. Functional aortic stenosis. A malformation characterized by resistance to left ventricular outflow without anatomic obstruction//Circulation. 1959. Vol. 20 (2). P. 181-189.
  • Morrow A.G., Brockenbrough E.C. Surgical treatment of idiopathic hypertrophic subaortic stenosis//Ann. Surg. 1961. Vol. 154. P. 181-189.
  • Wigle E.D., Auger P., Marquis Y. Muscular subaortic stenosis:the initial left ventricular inflow tract pressure as evidence of outflow tract obstruction//Can. Med. Assoc. J. 1966. Vol. 95 (16). P. 793-797.
  • Braunwald E., Ebert P.A. Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs//Am. J. Cardiol. 1962. Vol. 10. P. 489-495.
  • Brockenbrough E.C., Braunwald E., Morrow A.G. A hemodynamic technique for the detection of hypertrophic subaortic stenosis//Circulation. 1961. Vol. 23. P. 189-194. doi: 10.1161/01. CIR.23.2.189.
  • Harrison D.C., Braunwald E., Glick G., Mason D.T., Chidsey C.A., Ross J.Jr. Effects of beta-adrenergic blockade on the Circulation with particular reference to observations in patients with hypertrophic subaortic stenosis//Circulation. 1964. Vol. 29. P. 84-98.
  • Braunwald U., Brockenbrough E.C., Morrow A.G. Editorial. Hypertropic Subaortic Stenosis -A Broadened Concept//Circulation. 1962. Vol. 26 (2). P. 161-166.
  • Criley J.M., Lewis K.B., White R.I., Ross R.S. Pressure gradients without obstruction: a new concept of “hypertrophic subaortic stenosis”//Circulation. 1965. Vol. 32 (6). P. 881-887.
  • Criley J.M., Siegel R.J. Has “obstruction” hindered our understanding of hypertrophic cardiomyopathy?//Circulation. 1985. Vol. 72 (6). P. 1148-1154.
  • Shah P.M., Gramiak R., Kramer D.H. Ultrasound localization of left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy//Circulation. 1969. Vol. 40 (1). P. 3-11.
  • Shah P.M., Gramiak R., Adelman A.G., Wigle E.D. Role of echocardiography in diagnostic and hemodynamic assessment of hypertrophic subaortic stenosis//Circulation. 1971. Vol. 44 (5). P. 891-898.
  • Abbasi A.S., MacAlpin R.N., Eber L.M., Pearce M.L. Echocardiographic diagnosis of idiopathic hypertrophic cardiomyopathy without outflow obstruction//Circulation. 1972. Vol. 46 (5). P. 897-904.
  • Abbasi A.S., MacAlpin R.N., Eber L.M., Pearce M.L. Left ventricular hypertrophy diagnosed by echocardiography//N. Engl. J. Med. 1973. Vol. 289 (3). P. 118-121.
  • Maron B.J., Clark C.E., Henry W.L., Fukuda T., Edwards J.E., Mathews E.C. Jr., Redwood D.R., Epstein S.E. Prevalence and characteristics of disproportionate ventricular septal thickening in patients with acquired or congenital heart disease: echocardiographic and morphologic findings//Circulation. 1977. Vol. 55 (3). P. 489-496.
  • Maron B.J., Savage D.D., Clark C.E., Henry W.L., Vlodaver Z., Edwards J.E., Epstein S.E. Prevalence and characteristics of disproportionate ventricular septal thickening in patients with coronary artery disease//Circulation. 1978. Vol. 57 (2). P. 250-255.
  • Maron B.J., Edwards J.E., Epstein S.E. Disproportionate ventricular thickening in patients with systemic hypertension//Chest. 1978. Vol. 73 (4). P. 466-470.
  • Henry W.L., Clark C.E., Glancy D.L., Epstein S.E. Echocardiographic measurement of the left ventricular outflow gradient in idiopathic hypertrophic subaortic stenosis//N. Engl. J. Med. 1973. Vol. 288 (19). P. 989-993
  • Maron B.J., Epstein S.E. Hypertrophic cardiomyopathy: a discussion of nomenclature//Am. J. Cardiol. 1979. Vol. 43 (6). P. 1242-1244.
  • Maron B.J., Gottdiener J.S., Epstein S.E. Patterns and significance of the distribution of left ventricular hypertrophy in a large population of patients with hypertrophic cardiomyopathy: A wide-angle two-dimensional echocardiographic study//Am. J. Cardiol. 1981. Vol. 48 (3). P. 418-428.
  • Yock P.G., Hatle L., Popp R.L. Patterns and timing of Doppler-detected intracavitary and aortic flow in hypertrophic cardiomyopathy//J. Am. Coll. Cardiol. 1986. Vol. 8 (5). P. 1047-1058.
  • Sherrid M.V., Chu C.K., Delia E., Mograder A., Dwyer E.M. Jr. An echocardiography study of the fluid mechanics of obstruction in hypertrophic cardiomyopathy//J. Am. Coll. Cardiol. 1993. Vol. 22 (3). P. 816-825.
  • Sasson Z., Henderson M., Wilansky S., Rakowski H., Wigle E.D. Causal relation between the pressure gradient and left ventricular ejection time in hypertrophic cardiomyopathy//J. Am. Coll. Cardiol. 1989. Vol. 13 (6). P. 1275-1279.
  • Pollick C., Rakowski H., Wigle E.D. Muscular subaortic stenosis: the quantitative relationship between systolic anterior motion and the pressure gradient//Circulation. 1984. Vol. 69 (1). P. 43-49.
  • Panza J.A., Petrone R.K., Fananapazir L., Maron B.J. Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy//J. Am. Coll. Cardiol. 1992. Vol. 19 (1). P. 91-99.
  • Spirito P., Maron B.J., Rosing D.R. Morphologic determinants of hemodynamic state following ventricular septal myotomy-myectomy in patients with hypertrophic cardiomyopathy: M-mode and two-dimensional echocardiographic assessment//Circulation. 1984. Vol. 70 (6). P. 984-995.
  • Maron B.J., Gottdiener J.S., Arce J., Rosing D.R., Wesley Y.E., Epstein S.E. Dynamic subaortic obstruction in hypertrophic cardiomyopathy: analysis by pulsed Doppler echocardiography//J. Am. Coll. Cardiol. 1985. Vol. 6 (1). P. 1-18.
  • Murgo J.P., Alter B.R., Dorethy J.F., Altobelli S.A., McGranahan G.M.Jr. Dynamics of left ventricular ejection in obstructive and nonobstructive hypertrophic cardiomyopathy//J. Clin. Invest. 1980. Vol. 66 (6). P. 1369-1382.
  • Murgo J.P. Does outflow obstruction exist in hypertrophic cardiomyopathy?//N. Engl. J. Med. 1982. Vol. 307 (16). P. 1008-1009.
  • Maron B.J., Maron M.S. The 20 advances that have defined contemporary hypertrophic cardiomyopathy//Trends in cardiovascular medicine. 2015. Vol. 25 (1). P. 54-64. doi: 10.1016/j. tcm.2014.09.004.
  • Coats C.J., Hollman A. Hypertrophic cardiomyopathy: lessons from history//Heart. 2008. Vol. 94 (10). P. 1258-1263. doi:10.1136/hrt.2008.153452.
  • Morrow A.G., Brockenbrough E.C. Surgical treatment of idiopathic hypertrophic subaortic stenosis//Ann. Surg. 1961. Vol. 154. P. 181-189.
  • Kirklin J.W., Ellis F.H. Surgical relief of diffuse subvalvular aortic stenosis//Circulation. 1961. Vol. 24. P. 739-742.
  • Falicov R.E., Resnekov L., Bharati S., Lev M. Mid-ventricular obstruction: a variant of obstructive cardiomyopathy//Am. J. Cardiol. 1976. Vol. 37 (3). P. 432^37.
  • Cooley D.A., Leachman R.D., Wukasch D.C. Mitral valve replacement for idiopathic hypertrophic cardiomyopathy//J. Cardiovasc. Surg. 1976. Vol. 17 (5). P. 380-387.
  • McIntosh C.L., Greenberg G.J., Maron B.J., Leon M.B., Cannon R.O. 3rd., Clark R.E. Clinical and hemodynamic results after mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy//Ann. Thorac. Surg. 1989. Vol. 47 (2). P. 236-246.
  • McIntosh C.L., Maron B.J., Cannon R.O. 3rd., Klues H.G. Initial results of combined anterior mitral leaflet plication and ventricular septal myotomy-myectomy for relief of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy//Circulation. 1992. Vol. 86 (5 Suppl). P. II60-7.
  • Messmer B.J. Extended myectomy for hypertrophic obstructive cardiomyopathy//Ann. Thorac. Surg. 1994. Vol. 58 (2). P. 575-577.
  • Swistel D.G., DeRose J.J. Jr., Sherrid M.V. Management of patients with complex hypertrophic cardiomyopathy: resection/plication/release//Oper. Tech. Thorac. Cardiovasc. Surg. 2004. Vol. 9 (4). P. 261-267 DOI: 10.1053/j.optechstcvs.2004.10.002
  • Бокерия Л.А. Гипертрофическая обструктивная кардиомиопатия//Анналы хирургии. 2013. № 5. С. 5-14.
  • Малеков Д.А., Санакоев М.К., Нехай Ю.А., Тетвадзе И.В., Берсенева М.И., Бокерия Л.А. Наш опыт двужелудочковой миоэктомии межжелудочковой перегородки при гипертрофической обструктивной кардиомиопатии//Бюллетень НЦССХ им. А.Н. Бакулева РАМН Сердечно-сосудистые заболевания. 2015. Т. 16. № S3. С. 95.
  • Бокерия Л.А., Борисов К.В., Синев А.Ф. Оригинальный способ хирургической коррекции гипертрофической обструктивной кардиомиопатии и комплексный подход к ее лечению//Грудная и сердечно-сосудистая хирургия. 1997. № S2. С. 80.
  • Bogachev-Prokophiev A., Zheleznev S., Fomenko M., Pivkin A., Afanasiev A., Sharifulin R., Karaskov A. Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy//J. Cardiothorac. Surg. 2015. Vol. 10 (Suppl 1). P. A139 DOI: 10.1186/1749-8090-10-S1-A139
  • Bogachev-Prokophiev A., Zheleznev S., Fomenko M., Pivkin A., Afanasiev A., Sharifulin R., Karaskov A. Mitral Subvalvular Apparatus Intervention In Patients With Obstructive Hypertrophic Cardiomyopathy: does it need?//J. Cardiothorac. Surg. 2015 Vol. 10 (Suppl 1). P. A138.
  • Ommen S.R., Maron B.J., Olivotto I., Olivotto I., Maron M.S., Cecchi F., Betocchi S., Gersh B.J., Ackerman M.J., McCully R.B., Dearani J.A., Schaff H.V., Danielson G.K., Tajik A.J., Nishimura R.A. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy//J. Am. Coll. Cardiol. 2005. Vol. 46 (3). P. 470-476.
  • Jeanrenaud X., Goy J.J., Kappenberger L. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy//Lancet. 1992. Vol. 339 (8805). P. 1318-1323.
  • Slade A.K.B., Sadoul N., Shapiro L., Chojnowska L., Simon J.P., Saumarez R.C., Dodinot B., Camm A.J., McKenna W.J., Aliot E. DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience//Heart. 1996. Vol. 75 (1). P. 44-9.
  • Fananapazir L., Epstein N.D., Curiel R.V., Panza J.A., Tripodi D., McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy//Circulation. 1994. Vol. 90 (6). P. 2731-2742.
  • Nishimura R.A., Trusty J.M., Hayes D.L., Ilstrup D.M., Larson D.R., Hayes S.N., Allison T.G., Tajik A.J. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind crossover study//J. Am. Coll. Cardiol. 1997. Vol. 29 (2). P. 435-441.
  • Maron B.J., Nishimura R.A., McKenna W.J., Rakowski H., Josephson M.E., Kieval R.S. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY)//Circulation. 1999. Vol. 99 (22). P. 2927-2933.
  • Linde C., Gadler F., Kappenberger L., Rydén L. Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy//Am. J. Cardiol. 1999. Vol. 83 (6). P. 903-907.
  • Sigwart U. Non-surgical myocardial reduction of hypertrophic obstructive cardiomyopathy//Lancet. 1995. Vol. 346 (8969). P. 211-214.
  • Kuhn H.J. The history of alcohol septal ablation//Cardiovascular Revascularization Medicine. 2010. Vol. 11 (4). P. 260-261 DOI: 10.1016/j.carrev.2009.11.003
  • Goodwin J.F., Oakley C.M. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy//Lancet. 1995. Vol. 346 (8990). P. 1624.
  • Sigwart U. Author’s reply//Lancet 1995. Vol. 346 (1995). P. 1624.
  • Maron B.J., Shen W.K., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., Bardy G.H., Favale S., Rea R.F., Boriani G., Estes N.A. 3rd., Spirito P. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy//N. Engl. J. Med. 2000. Vol. 342 (6). P. 365-373.
  • Maron B.J., Spirito P., Shen W.K., Haas T.S., Formisano F., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., Lawrenz T., Boriani G., Estes N.A. 3rd, Favale S., Piccininno M., Winters S.L., Santini M., Betocchi S., Arribas F., Sherrid M.V., Buja G., Semsarian C., Bruzzi P. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy//J. Am. Med. Assoc. 2007. Vol. 298 (4). P. 405-412
  • Богачев-Прокофьев А.В., Железнев С.И., Фоменко М.С., Афанасьев А.В., Шарифулин Р.М., Назаров В.М., Малахова О.Ю., Караськов А.М. Протезирование или сохранение митрального клапана: выбор оптимальной тактики хирургического лечения обструктивной гипертрофической кардиомиопатии//Патология кровообращения и кардиохирургия. 2015. Т. 19. № 4. С. 26-33.
  • Богачев-Прокофьев А.В., Железнев С.И., Фоменко М.С., Афанасьев А.В., Шарифулин Р.М., Пивкин А.Н., Демидов Д.П., Караськов А.М. Первый опыт расширенной миоэктомии при хирургическом лечении обструктивной гипертрофической кардиомиопатии: непосредственные и промежуточные результаты//Патология кровообращения и кардиохирургия. 2015. Т. 19. № 2. С. 20-25.
  • Maron B.J., Spirito P., Ackerman M.J., Casey S.A., Semsarian C., Estes N.A. 3rd, Shannon K.M., Ashley E.A., Day S.M., Pacileo G., Formisano F., Devoto E., Anastasakis A., Bos J.M., Woo A., Autore C., Pass R.H., Boriani G., Garberich R.F., Almquist A.K., Russell M.W., Boni L., Berger S., Maron M.S., Link M.S. Prevention of sudden cardiac death with the implantable cardioverter-defibrillator in children and adolescents with hypertrophic cardiomyopathy//J. Am. Coll. Cardiol. 2013. Vol. 61 (14). P. 1527-1535 DOI: 10.1016/j.jacc.2013.01.037
Еще
Статья обзорная